The European Total Pharmaceutical Market by country, expressed in 2024 generics in volume, shows Slovakia (63.2) and the Czech Republic (62.3) leading in generics consumption. Meanwhile, Belgium (37.3), France (33.5), Italy (28.6), and Switzerland (24) follow. In 2023, Slovakia and the Czech Republic experienced a slight decrease in generics volume share by -0.41% and -0.35%, respectively. Conversely, Belgium (1.17%), France (2.3%), Italy (2.56%), and Switzerland (2.9%) all observed positive changes indicating growth in preference for generics.
Future trends to watch for in the European Total Pharmaceutical Market by country include the increasing adoption of generics driven by cost-saving measures and supportive government policies. Continuous monitoring of regulatory changes, innovation in generic drug production, and the impact of demographic shifts on pharmaceutical consumption will be essential.
Top countries in Total Pharmaceutical Market by Country
| # | 6 Countries | Percent of Generics in Volume | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Slovakia | 63.2 | 2023 | -0.47% | -0.41% | View data |
| 2 | 2 Czech Republic | 62.3 | 2023 | -0.32% | -0.35% | View data |
| 3 | 3 Belgium | 37.3 | 2023 | +1.91% | +1.17% | View data |
| 4 | 4 France | 33.5 | 2023 | +2.76% | +2.3% | View data |
| 5 | 5 Italy | 28.6 | 2023 | +3.25% | +2.56% | View data |
| 6 | 6 Switzerland | 24 | 2023 | +3% | +2.9% | View data |
